These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 24486177

  • 1. Iron treatment and inflammatory bowel disease: what happens in real practice?
    Lugg S, Beal F, Nightingale P, Bhala N, Iqbal T.
    J Crohns Colitis; 2014 Aug; 8(8):876-80. PubMed ID: 24486177
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Pathophysiological-based diagnosis and therapy of iron-deficient anaemia in inflammatory bowel disease].
    Stein JM, Hartmann F, Cordes HJ, Dignass AU.
    Z Gastroenterol; 2009 Feb; 47(2):228-36. PubMed ID: 19197827
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and tolerability of intravenous iron dextran and oral iron in inflammatory bowel disease: a case-matched study in clinical practice.
    Khalil A, Goodhand JR, Wahed M, Yeung J, Ali FR, Rampton DS.
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(11):1029-35. PubMed ID: 21857526
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Intravenous Iron Sucrose for Treatment of Iron Deficiency Anemia in Pediatric Inflammatory Bowel Disease.
    Stein RE, Plantz K, Maxwell EC, Mamula P, Baldassano RN.
    J Pediatr Gastroenterol Nutr; 2018 Feb; 66(2):e51-e55. PubMed ID: 28704225
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long-term extension data from a Phase 3 study.
    Schmidt C, Ahmad T, Tulassay Z, Baumgart DC, Bokemeyer B, Howaldt S, Stallmach A, Büning C, AEGIS Study Group.
    Aliment Pharmacol Ther; 2016 Aug; 44(3):259-70. PubMed ID: 27237709
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of the Efficacies of Parenteral Iron Sucrose and Oral Iron Sulfate for Anemic Patients with Inflammatory Bowel Disease in Korea.
    Han YM, Yoon H, Shin CM, Koh SJ, Im JP, Kim BG, Kim JS, Jung HC.
    Gut Liver; 2016 Jul 15; 10(4):562-8. PubMed ID: 27021505
    [Abstract] [Full Text] [Related]

  • 16. Safety and efficacy of intravenous iron isomaltoside for correction of anaemia in patients with inflammatory bowel disease in everyday clinical practice.
    Stein J, Walper A, Klemm W, Farrag K, Aksan A, Dignass A.
    Scand J Gastroenterol; 2018 Sep 15; 53(9):1059-1065. PubMed ID: 30222479
    [Abstract] [Full Text] [Related]

  • 17. Safety and efficacy of parenteral iron in children with inflammatory bowel disease.
    Papadopoulos M, Patel D, Korologou-Linden R, Goto E, Soondrum K, Fell JME, Epstein J.
    Br J Clin Pharmacol; 2018 Apr 15; 84(4):694-699. PubMed ID: 29266387
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.